Aurobindo Pharma

Pharma Stocks Surge After US Senate Passes Biosecure Act

Pharma stocks gained momentum on December 19 as the US Senate approved the Biosecure Act, a key provision within the fiscal 2026 National Defense Authorization Act (NDAA). This move, aimed at limiting certain Chinese biotech companies from receiving federal funding, sparked a positive reaction ac...

Q2 Results 2025 Today: Sun Pharma, Grasim, Britannia, Aurobindo Pharma & Delhivery Set to Announce September Quarter Earnings

The mid-week session on Dalal Street brings a heavy earnings lineup, even though the market remains shut today.A long list of companies is preparing to release their Q2 results 2025, turning the day into one of the busiest moments of the season.What makes the day interesting is the concentration ...

Stocks to Watch Today, 04 November: Key Earnings, Fundraises, and Deals in Focus

Stocks to Watch Today, 04 November: Key Results, Fundraising Plans, and Acquisitions in FocusThe share market today is expected to witness significant movement as multiple blue-chip and mid-cap companies report their September-quarter earnings. Major corporates including State Bank of India, Mahi...

Aurobindo Pharma, Lupin & Other Pharma Shares Gain as US Considers Excluding Generic Drugs from Tariffs

Market PerformancePharma shares witnessed notable gains on October 9, with Aurobindo Pharma, Lupin, and other leading companies rising up to 4% following news that the US administration is considering excluding generic drugs from tariffs. This development brought relief to Indian pharmaceutical f...